Column Capital Advisors’s Boston Scientific BSX Stock Holding History

Column Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$46K	Hold	872	–	–	0.01%	336
2023 Q2	$47.2K	Sell	872 -545	-38%	-$28.5K	0.01%	331
2023 Q1	$70.9K	Sell	1,417 -76	-5%	-$3.58K	0.01%	273
2022 Q4	$69.1K	Hold	1,493	–	–	0.01%	255
2022 Q3	$58K	Hold	1,493	–	–	0.01%	252
2022 Q2	$56K	Hold	1,493	–	–	0.01%	261
2022 Q1	$66K	Hold	1,493	–	–	0.01%	257
2021 Q4	$63K	Sell	1,493 -22	-1%	-$924	0.01%	263
2021 Q3	$66K	Sell	1,515 -2	-0.1%	-$88	0.01%	234
2021 Q2	$65K	Sell	1,517 -68	-4%	-$2.86K	0.01%	232
2021 Q1	$61K	Hold	1,585	–	–	0.01%	241
2020 Q4	$57K	Buy	1,585 +3	+0.2%	+$108	0.01%	243
2020 Q3	$60K	Sell	1,582 -319	-17%	-$12.3K	0.02%	223
2020 Q2	$66K	Buy	1,901 +861	+83%	+$31K	0.02%	204
2020 Q1	$34K	Buy	1,040 +3	+0.3%	+$117	0.01%	247
2019 Q4	$46K	Buy	+1,037	New	+$43.4K	0.02%	251

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Column Capital Advisors's BSX Position: Q3 2023 in Review

Column Capital Advisors held its Boston Scientific (BSX) position steady in Q3 2023 at 872 shares worth $46K. The position accounts for 0.01% of the portfolio, ranked #336.

Column Capital Advisors first reported a position in BSX in Q4 2019 and has held it in 16 quarters since. The position peaked at $70.9K in Q1 2023. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.

Column Capital Advisors held 872 shares of Boston Scientific worth $46K as of Q3 2023.
Column Capital Advisors left its Boston Scientific share count unchanged in Q3 2023.
Boston Scientific made up 0.01% of Column Capital Advisors's portfolio in Q3 2023, its #336 holding.
Column Capital Advisors first reported a position in Boston Scientific in Q4 2019 and has held it in 16 quarters since.
Column Capital Advisors's Boston Scientific position peaked at $70.9K in Q1 2023.
1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.